Interview with Petr Tor, Country Director, Stallergenes Czech Republic
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Institute of Health Information and Statistics of the Czech Republic (further on “the Institute“) was established in 1960. The Institute is an organisational component of the State; its founder is the Ministry of Health.
The National Health Information System (further on “NHIS“) is defined in Act no. 372/2011Sb, On health services and conditions of their provision (Act on health services) in Section 70, paragraph 1 (the Act is valid since April. 2012).
Administration of NHIS is delegated by MH to the Institute in accordance with the basic purpose and objective of its activity that follows from the Statute of the Institute. The extent of the mandate of the Institute is defined in Section 72, paragraph 1, letters a) to d) and f) of Act no. 372/2011Sb, on health services.
In handling personal data in NHIS the Institute proceeds in accordance with Act no. 101/2000 Sb., On personal data protection, in wording of later regulations.
The Institute is a component of the State Statistical Service (on the basis of the competence act) and performs this activity according to Act no. 89/1995 Sb., On state statistical service, in wording of later regulations. It cooperates with organs of State Statistical Service, mainly with Czech Statistical Office, it secures connection between NHIS and individual health care providers and it cooperates with the operators of information systems of other organisations in and out of the health sector.
The Institute will continue to follow the principles of the European Statistics Code of Practice that represents the common summary of European standards designated for statistical organs and for the whole European statistical system with the aim to secure high quality and credibility of European data. These principles concern, among other things, professional independence, confidentiality protection, reliability of the data and their precision, timeliness, punctuality, accessibility, intelligibility, clarity, comparability and consistency.
The Institute cooperates with associations of hospitals, associations of physicians, professional medical societies, health insurance companies and other organisations, particularly on precise specification of the NHIS contents and on utilisation of the collected data.
On the international level of health statistics the Institute cooperates particularly with WHO, OECD, the UN, EUROSTAT and other organisations. The Institute is the official presenter of NHIS data for the Czech Republic.
Contact
Institute of health information and statistics of the Czech Republic
Palackého nám. 4 , P.O.BOX 60,
128 01 Praha
email: uzis@uzis.cz
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Mr. Pfannenschmidt, you have been working for Boehringer Ingelheim for three decades, outlasting several company chairman and witnessing the birth and evolution of the corporate vision “Value through Innovation”. Before…
Mr. Bruzl, we often interview pharmaceutical managers that studied medicine, pharmaceutical science, or business—we do not interview many managers that have a background in law. How did you find yourself…
Infirmary and ultimately leading to a position heading the Czech Republic and Slovakian organization for Janssen. Can you begin by introducing yourself to our readers and giving them an overview…
The Czech Republic is home to Apotex’s oldest branch within a Europe, established in 1992. You yourself joined the organization in 1993. What has been this company’s growth trajectory in…
Mr. Bartoš, you are celebrating your 15th anniversary with Merck this year, and your international career has offered you the opportunity to work throughout Europe. Over these years, how have…
Mr. Pospíšil, you have quite an interesting background, with a degree in agricultural economy engineering. You eventually left the field in 1991 to consult for Lundbeck, building the business here.…
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern European pharma industry. The business has been present in Czechoslovakia since 1956, and has…
Dr. Janda, can you please begin by introducing our readers to the ACRO-CZ, and explicate its mission on this market? Mimicking the European standards, we also wanted to connect all…
Dr. Zörner, can you please begin by introducing our readers to the CAFF (Czech Association of Pharmaceutical Firms), and explicate its key activities and mission? We represent 24 companies in…
Mr. Březovký, can you begin with an introduction to SUKL and its role within the Czech Republic’s complex regulatory environment? I would like to begin by noting that I have…
In the Czech Republic, homeopathic medicines were prohibited during the communistic period, but found resurgence after 1989. Can you give us an overview of the development of this form of…
See our Cookie Privacy Policy Here